根据不同截止点和其与心脏代谢风险变量相关的重症手术患者的体重复发
Victor Giovanino Accetta1, Alessandra da Silva2, Sônia Lopes Pinto3
1Postgraduate Program in Health Sciences, Federal University of Tocantins, Palmas, Brazil.
Obesity surgery
|June 21, 2025
概括
减肥手术后体重复发 (WR) 与心脏代谢风险增加有关,即使复发率为15%. 这些风险仍然存在,随着体重的增加可能会恶化,突出显示需要监测手术后的体重变化.
科学领域:
- 代谢手术 代谢手术
- 肥胖医学 肥胖医学
- 心血管健康 心血管健康
背景情况:
- 减肥手术是严重肥胖症的关键治疗方法,但体重复发 (WR) 构成了重大挑战.
- 由于没有标准化对WR的定义,使其评估和理解相关的健康风险变得复杂.
研究的目的:
- 为了确定WR的患病率,使用各种减肥手术后的切断点.
- 调查WR和心脏代谢风险标志物之间的关联.
主要方法:
- 一项横截面的观察性研究包括95名患者,他们在两年前接受了减肥手术.
- 在15%,25%,35%和45%的值下分析了体重复发情况.
- 评估了人体测量和代谢变量,以确定与WR的关联.
主要成果:
- WR ≥15%与更高的胰岛素和HOMA-IR (胰岛素耐药性的恒温模型评估) 相关联.
- WR ≥25%与较低的费里和较高的TyG指数 (甘油三指数-葡萄糖指数) 有关.
- 首次,WR ≥35%与高甘油水平显著相关.
结论:
- 体重复发率为15%或以上与不良的心脏代谢风险标志物有关.
- 这些关联似乎持续存在,并可能随着体重复发的增加而加剧.
相关概念视频
01:24Obesity
627
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
627
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
184
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
184